[go: up one dir, main page]

WO2008028684A3 - Peptides with high affinity for the prolactin receptor - Google Patents

Peptides with high affinity for the prolactin receptor Download PDF

Info

Publication number
WO2008028684A3
WO2008028684A3 PCT/EP2007/007863 EP2007007863W WO2008028684A3 WO 2008028684 A3 WO2008028684 A3 WO 2008028684A3 EP 2007007863 W EP2007007863 W EP 2007007863W WO 2008028684 A3 WO2008028684 A3 WO 2008028684A3
Authority
WO
WIPO (PCT)
Prior art keywords
high affinity
peptides
prolactin receptor
prolactin
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/007863
Other languages
French (fr)
Other versions
WO2008028684A2 (en
Inventor
Kasper Rand
Mette Dahl Andersen
Ole Hvilsted Olsen
Jens Breinholt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority to PCT/EP2008/052784 priority Critical patent/WO2009003732A2/en
Priority to EP08717531A priority patent/EP2167116A2/en
Publication of WO2008028684A2 publication Critical patent/WO2008028684A2/en
Publication of WO2008028684A3 publication Critical patent/WO2008028684A3/en
Priority to PCT/EP2008/058589 priority patent/WO2009004057A2/en
Priority to PCT/EP2008/058593 priority patent/WO2009004058A2/en
Priority to EP08802942A priority patent/EP2167059A2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57554—Prolactin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to variants of prolactin, which variants have high affinity for the prolactin receptor.
PCT/EP2007/007863 2006-09-08 2007-09-10 Peptides with high affinity for the prolactin receptor Ceased WO2008028684A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/EP2008/052784 WO2009003732A2 (en) 2007-07-05 2008-03-07 Peptides with high affinity for the prolactin receptor
EP08717531A EP2167116A2 (en) 2007-07-05 2008-03-07 Peptides with high affinity for the prolactin receptor
PCT/EP2008/058589 WO2009004057A2 (en) 2007-07-05 2008-07-03 Mutated dimeric prolactin receptor ligands
PCT/EP2008/058593 WO2009004058A2 (en) 2007-07-05 2008-07-03 Novel prolactin compounds
EP08802942A EP2167059A2 (en) 2007-07-05 2008-07-03 Novel prolactin compounds

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP06120388 2006-09-08
EP06120388.1 2006-09-08
EP06121683.4 2006-10-03
EP06121683 2006-10-03
EP07111799.8 2007-07-05
EP07111799 2007-07-05

Publications (2)

Publication Number Publication Date
WO2008028684A2 WO2008028684A2 (en) 2008-03-13
WO2008028684A3 true WO2008028684A3 (en) 2008-06-12

Family

ID=38969504

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/007863 Ceased WO2008028684A2 (en) 2006-09-08 2007-09-10 Peptides with high affinity for the prolactin receptor

Country Status (1)

Country Link
WO (1) WO2008028684A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058142A1 (en) * 1998-05-12 1999-11-18 Chen Wen Y Use of anti-prolactin agents to treat proliferative conditions
US6780613B1 (en) * 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780613B1 (en) * 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
WO1999058142A1 (en) * 1998-05-12 1999-11-18 Chen Wen Y Use of anti-prolactin agents to treat proliferative conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLEVENGER C V ET AL: "The role of prolactin in mammary carcinoma", ENDOCRINE REVIEWS, BALTIMORE, MD, US, vol. 24, no. 1, February 2003 (2003-02-01), pages 1 - 27, XP002408798 *

Also Published As

Publication number Publication date
WO2008028684A2 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
WO2007041635A3 (en) Fc variants with optimized fc receptor binding properties
WO2006105338A3 (en) Fc VARIANTS WITH OPTIMIZED PROPERTIES
WO2009070243A3 (en) Wise binding antibodies and epitopes
WO2009113828A3 (en) Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
WO2008121767A3 (en) Stitched polypeptides
WO2011072099A3 (en) Compositions and methods comprising protease variants
WO2008060705A8 (en) Anti-dll4 antibodies and methods using same
WO2009052400A8 (en) Antibodies that bind to mammalian ngal and uses thereof
MY156315A (en) Anti-vegf antibodies
WO2006066594A3 (en) Alpha-amylase variants
WO2009067674A3 (en) Polymorphs of sunitinib base and processes for preparation thereof
WO2007101698A3 (en) Modified molecules which promote hematopoiesis
WO2009130479A3 (en) Virus
CA2705357C (en) Formulations for taci-immunoglobulin fusion proteins
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
WO2008048519A3 (en) Antibodies that bind cxcr7 epitopes
WO2009004593A3 (en) Processes for the preparation of epinephrine
WO2007127506A3 (en) Anti-ephrinb2 antibodies and methods using same
PL1987357T3 (en) Polypeptides recognized by anti-trichinella antibodies, and uses thereof
WO2008075205A3 (en) Improved process for the preparation of voriconazole
WO2009047794A3 (en) Docetaxel injectable composition, being absolutely free of ethanol
WO2009103813A3 (en) Fungicidal compositions comprising 3'-bromine-2,3,4,6'-tetramethoxy-2'-6-dimethylbenzophenone
WO2008030564A3 (en) Aglycosylated antibodies and methods of making and using those antibodies
SI2064185T1 (en) 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions
WO2009003732A3 (en) Peptides with high affinity for the prolactin receptor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07802239

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07802239

Country of ref document: EP

Kind code of ref document: A2